The symposium, themed "Neural and Immune Codes in Cancer" will gather an interdisciplinary community of researchers to discuss the interplay between the neural and immune systems in relation to cancer initiation, progression and therapy. This symposium will emphasise the dynamic interactions among tumour cells, neurons and immune components, and how these relationships impact tumour growth, metastasis and the tumour microenvironment.

As a winner of the Outstanding Mid-Career Researcher Award, Inês Pires da Silva was recognised for her exceptional progress and global impact in translational cancer research. She has led international studies that have shaped current clinical practice and advanced scientific understanding of resistance mechanisms in immunotherapy.

Since the 1990s, non-invasive brain stimulation has grown from an experimental idea into an established tool for treating depression as well as advancing neuroscience research. Among these technologies, repetitive transcranial magnetic stimulation (rTMS) is clinically validated and used to treat major depressive disorder, also known as unipolar depression.

Thinking about the past and how it shaped the present is never simple. But Zach Mainen, who has been here since day one, was a natural person to revisit the “Then and Now” of the Champalimaud Foundation (CF). We spoke about what it meant to take on a new and unpredictable project, and how the dream of a small group gradually became reality. I hope this story inspires you to step into the unknown and to trust that even when the future feels uncertain, it can still unfold into something remarkable.

Maria João Villas-Boas has been close to the Champalimaud Foundation (CF) since its early days. “I was fascinated, truly fascinated,” she told me as I asked when she had first heard about it. She had been following Leonor Beleza's work in the press, and the clarity of her clear vision for the CF made a lasting impression.

One phone call set everything in motion. It changed Leonor Beleza’s life and ultimately shaped the lives of countless others who would one day find their way to the Champalimaud Foundation (CF). It was not just a phone call, of course, but the culmination of everything Leonor had built over decades of public service, women's rights advocacy, political experience and a deep belief that institutions exist to serve people.

Megan Carey visited Portugal for the first time in August 2005. She and her husband, Michael Orger, had been invited to a wedding, and a Portuguese friend (André Valente) had promised to show them all the good things that Lisbon had to offer. At the time, Megan was a postdoctoral researcher at Harvard Medical School. Amidst some difficulty finding the Capela de São Jerónimo, the discomfort of walking in high heels on the traditional Portuguese cobblestones, and the heat, she remembers rolling her eyes when Mike first suggested: "Lisbon is incredible, one day we should live here!" 

Adam was one of the investigators who helped shape the early days of the Champalimaud Centre for the Unknown and the Champalimaud Neuroscience Programme.

He was an innovator in the truest sense: a scientist who built microscopes, created tools like Bonsai and Harp, and pushed the boundaries of what could be done through radical collaboration. He brought joy, curiosity, and generosity to every interaction, and he had an extraordinary gift for bringing people together.

Even after moving to London, Adam kept a special and enduring connection to the Champalimaud Foundation.

Vision is central to how humans navigate the world, whether recognizing a familiar face in a photo or driving to a family dinner. For Artificial Intelligence (AI), however, even minor visual distortions, such as changes in brightness, contrast, or subtle perturbations, can cause object recognition algorithms to fail. Bridging this performance gap has been a major challenge in machine learning.

Today, the European Research Council (ERC) announced the results of its latest Consolidator Grants call, the second level of this type of funding, for researchers with consolidated work in their fields. Two new life science projects in Portugal secured a combined total of €4.1M. These grants were awarded to Juan Álvaro Gallego, who recently joined the CF, and Ricardo Araújo from Instituto Superior Técnico / Centro de Recursos Naturais e Ambiente (CERENA) .